Literature DB >> 15532033

Accepting its random coil nature allows a partial NMR assignment of the neuronal Tau protein.

Caroline Smet1, Arnaud Leroy, Alain Sillen, Jean-Michel Wieruszeski, Isabelle Landrieu, Guy Lippens.   

Abstract

A combined strategy to obtain a partial NMR assignment of the neuronal Tau protein is presented. Confronted with the extreme spectral degeneracy that the spectrum of this 441 amino acid long unstructured protein presents, we have introduced a graphical procedure based on residue type-specific product planes. Combining this strategy with the search for pairwise motifs, and combining the spectra of different Tau isoforms and even of peptides derived from the native sequence, we arrive at a partial assignment that is sufficient to map the interactions of Tau with its molecular partners. The obtained assignments equally confirm the absence of regular secondary structure in the isolated protein.

Mesh:

Substances:

Year:  2004        PMID: 15532033     DOI: 10.1002/cbic.200400145

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  25 in total

1.  Motional properties of unfolded ubiquitin: a model for a random coil protein.

Authors:  Julia Wirmer; Wolfgang Peti; Harald Schwalbe
Journal:  J Biomol NMR       Date:  2006-07       Impact factor: 2.835

Review 2.  To be disordered or not to be disordered: is that still a question for proteins in the cell?

Authors:  Kris Pauwels; Pierre Lebrun; Peter Tompa
Journal:  Cell Mol Life Sci       Date:  2017-06-13       Impact factor: 9.261

3.  Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins.

Authors:  Clément Danis; Clément Despres; Luiza M Bessa; Idir Malki; Hamida Merzougui; Isabelle Huvent; Haoling Qi; Guy Lippens; François-Xavier Cantrelle; Robert Schneider; Xavier Hanoulle; Caroline Smet-Nocca; Isabelle Landrieu
Journal:  J Vis Exp       Date:  2016-12-27       Impact factor: 1.355

4.  Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E.

Authors:  Arnaud Leroy; Isabelle Landrieu; Isabelle Huvent; Dominique Legrand; Bernadette Codeville; Jean-Michel Wieruszeski; Guy Lippens
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

5.  Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats.

Authors:  Elka R Georgieva; Shifeng Xiao; Peter P Borbat; Jack H Freed; David Eliezer
Journal:  Biophys J       Date:  2014-09-16       Impact factor: 4.033

6.  Remodeling of the conformational ensemble of the repeat domain of tau by an aggregation enhancer.

Authors:  Elias Akoury; Marco D Mukrasch; Jacek Biernat; Katharina Tepper; Valery Ozenne; Eckhard Mandelkow; Martin Blackledge; Markus Zweckstetter
Journal:  Protein Sci       Date:  2016-03-24       Impact factor: 6.725

7.  3-O-Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular Uptake.

Authors:  Jing Zhao; Yanan Zhu; Xuehong Song; Yuanyuan Xiao; Guowei Su; Xinyue Liu; Zhangjie Wang; Yongmei Xu; Jian Liu; David Eliezer; Trudy F Ramlall; Guy Lippens; James Gibson; Fuming Zhang; Robert J Linhardt; Lianchun Wang; Chunyu Wang
Journal:  Angew Chem Int Ed Engl       Date:  2019-12-10       Impact factor: 15.336

Review 8.  The structure and phase of tau: from monomer to amyloid filament.

Authors:  Yifan Zeng; Jing Yang; Bailing Zhang; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Mol Life Sci       Date:  2020-10-19       Impact factor: 9.261

Review 9.  Intrinsically disordered proteins in the neurodegenerative processes: formation of tau protein paired helical filaments and their analysis.

Authors:  Rostislav Skrabana; Jozef Sevcik; Michal Novak
Journal:  Cell Mol Neurobiol       Date:  2006-06-16       Impact factor: 5.046

Review 10.  In-Cell NMR Spectroscopy of Intrinsically Disordered Proteins.

Authors:  Nicholas Sciolino; David S Burz; Alexander Shekhtman
Journal:  Proteomics       Date:  2019-01-15       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.